These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11566017)

  • 1. GM-611 (Chugai Pharmaceutical).
    Peeters TL
    Curr Opin Investig Drugs; 2001 Apr; 2(4):555-7. PubMed ID: 11566017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility.
    Sanger GJ; Westaway SM; Barnes AA; Macpherson DT; Muir AI; Jarvie EM; Bolton VN; Cellek S; Näslund E; Hellström PM; Borman RA; Unsworth WP; Matthews KL; Lee K
    Neurogastroenterol Motil; 2009 Jun; 21(6):657-64, e30-1. PubMed ID: 19374732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs.
    Ozaki K; Sudo H; Muramatsu H; Yogo K; Kamei K; Koga H; Itoh Z; Omura S; Takanashi H
    Inflammopharmacology; 2007 Feb; 15(1):36-42. PubMed ID: 17323194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine.
    Takanashi H; Yogo K; Ozaki K; Koga H; Itoh Z; Omura S
    Pharmacology; 2007; 79(3):137-48. PubMed ID: 17183187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs.
    Ozaki K; Yogo K; Sudo H; Onoma M; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Pharmacology; 2007; 79(4):223-35. PubMed ID: 17426410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
    Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum.
    Satoh M; Sakai T; Sano I; Fujikura K; Koyama H; Ohshima K; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1994 Oct; 271(1):574-9. PubMed ID: 7965757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.
    Weber FH; Richards RD; McCallum RW
    Am J Gastroenterol; 1993 Apr; 88(4):485-90. PubMed ID: 8470625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.
    Jarvie EM; North Laidler VJ; Corcoran S; Bassil A; Sanger GJ
    Br J Pharmacol; 2007 Feb; 150(4):455-62. PubMed ID: 17211452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Motilide, motilin-like macrolides].
    Omura S; Inatomi N; Itoh Z
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1881-90. PubMed ID: 8210432
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism and clinical application of erythromycin as a gastrointestinal prokinetic agent in children].
    Yang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):102-4. PubMed ID: 18289489
    [No Abstract]   [Full Text] [Related]  

  • 12. An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs.
    Inatomi N; Satoh H; Maki Y; Hashimoto N; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1989 Nov; 251(2):707-12. PubMed ID: 2810120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
    Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders].
    Peeters TL
    Z Gesamte Inn Med; 1991 Aug; 46(10-11):349-54. PubMed ID: 1926941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate.
    Westaway SM; Brown SL; Fell SC; Johnson CN; MacPherson DT; Mitchell DJ; Myatt JW; Stanway SJ; Seal JT; Stemp G; Thompson M; Lawless K; McKay F; Muir AI; Barford JM; Cluff C; Mahmood SR; Matthews KL; Mohamed S; Smith B; Stevens AJ; Bolton VJ; Jarvie EM; Sanger GJ
    J Med Chem; 2009 Feb; 52(4):1180-9. PubMed ID: 19191554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EM574, an erythromycin derivative, is a motilin receptor agonist in the rabbit.
    Sato F; Sekiguchi M; Marui S; Inatomi N; Shino A; Itoh Z; Omura S
    Eur J Pharmacol; 1997 Mar; 322(1):63-71. PubMed ID: 9088872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of interstitial cells of Cajal on gastrointestinal motility induced by motilin receptor agonist ABT-229].
    Wang CH; Wang LC; Jiang X; Lan L; Liu L; Sun Y; Wang BX
    Zhonghua Er Ke Za Zhi; 2010 Apr; 48(4):254-9. PubMed ID: 20654011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9-Dihydroerythromycins as non-antibiotic motilin receptor agonists.
    Liu Y; Li Y; Chen Y; Zheng H; Claypool M; Myles DC; Carreras CW
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5658-61. PubMed ID: 20801039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motilin and ghrelin as prokinetic drug targets.
    De Smet B; Mitselos A; Depoortere I
    Pharmacol Ther; 2009 Aug; 123(2):207-23. PubMed ID: 19427331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of motilin in the hypothalamus and the effect of central erythromycin on gastric motility in diabetic rats.
    Jia YD; Liu CQ; Tang M; Jiang ZY
    Neurosci Bull; 2007 Mar; 23(2):75-82. PubMed ID: 17592529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.